Project Grant F32AI186388

Award Date 1/12/25
Completion Date Not listed
Dollars Obligated $77K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $532,978 to The University of Iowa to conduct research on the placental tissue tropism and cellular mechanisms of Ebola virus (EBOV) transmission from mother to fetus during pregnancy. The key objectives of this project are to: 1) Define the tropism of EBOV in the placenta during early and late pregnancy,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $242,310 to establish an in vitro model of intestinal filovirus infection using human induced pluripotent stem cell-derived intestinal organoids. The primary goals are to: 1) characterize the impact of filovirus infection on intestinal barrier and tight junction integrity, which may contribute to the severe...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $387,783 in funding to The Pennsylvania State University to conduct research on the host-induced changes in pathogenic human viral dynamics, with a focus on the critical steps of virus entry into human host cells. The research program aims to unravel the dynamics of host entry for several classes of pathogenic icosahedral viruses,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $729,006 over a period of 5 years starting January 14, 2025 to study how the adenovirus manipulates host RNA binding proteins to support viral infection. The research will employ advanced proteomics and imaging techniques to define the mechanisms by which the adenovirus alters RNA-protein complexes and evades...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to better understand the molecular mechanisms of HIV spread through cell-cell contact across a virological synapse (VS). The $515,282 award will enable Case Western Reserve University (CWRU) to develop a novel flow cytometry assay for quantifying and purifying infected cell-target cell pairs, and leverage...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $194,616 to Emory University for the development of virus-like particles (VLPs) to support HIV-1 cure strategies. The key objectives are to: 1) Use VLPs to deliver the HIV-1 Tat protein as a latency reversing agent to reactivate latent HIV-1 proviruses, and 2) Utilize VLPs to deliver the Cas12k enzyme fused to HIV-1...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to investigate the anti-viral functions of the APOBEC3B enzyme that do not require its deaminase activity. The $228,435 award, effective from January 2, 2025 to December 31, 2026, will be used by the University of California, Irvine to: Explain how APOBEC3B modulates the PKR signaling pathway to promote translation arrest,...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $194,616 to investigate the role of arginine methylation in regulating host protein interactions during human adenovirus infection. The research aims to determine how the adenoviral 100kDa protein acts as a "molecular sponge" to sequester protein arginine methyltransferase 1 (PRMT1) activity,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $436,144.00 to Virginia Commonwealth University (VCU) to conduct research on how the bacterial pathogen Anaplasma phagocytophilum exploits the process of regulated exocytosis to facilitate its release and dissemination. The key objectives of this award are to 1) investigate the role of intracellular calcium...
This $290,132 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to define how the cellular protein SLBP (stem-loop binding protein) promotes the infectivity of human cytomegalovirus (HCMV). The overarching goal is to identify and characterize this novel, pro-viral function of SLBP during HCMV infection. The research will determine the specific SLBP function required to promote HCMV infectivity,...

FUNCTIONAL SIGNIFICANCE AND MECHANISMS OF EBOLA VIRUS VP24-HOST PROTEIN INTERACTIONS - PROJECT SUMMARY EBOLA VIRUS (EBOV) IS A MEMBER OF THE FILOVIRIDAE FAMILY OF NON-SEGMENTED, NEGATIVE SENSE RNA VIRUSES KNOWN TO CAUSE SPORADIC AND DEADLY OUTBREAKS. AMONG THE EIGHT MAJOR TRANSLATION PRODUCTS ENCODED IN THE FILOVIRUS GENOME, THE VIRAL PROTEIN 24 (VP24) IS CRUCIAL FOR THE PRODUCTION OF INFECTIOUS VIRAL PARTICLES, VIRAL NUCLEOCAPSID ASSEMBLY, AND THE SUPPRESSION OF IFN SIGNALING. TO SUPPRESS IFN SIGNALING, VP24 INTERACTS WITH HOST IMPORTIN- ALPHA (IMPA) NUCLEAR TRANSPORT PROTEINS TO COMPETITIVELY INHIBIT STAT1 INTERACTION WITH IMPA, PREVENTING STAT1 NUCLEAR IMPORT AND THE INDUCTION OF STAT1 DEPENDENT GENE EXPRESSION. WHILE THE VP24-IMPA INTERACTION IS WELL CHARACTERIZED IN THE SUPPRESSION OF IFN SIGNALING, LESS IS KNOWN ABOUT WHETHER THIS HAS ADDITIONAL FUNCTIONAL SIGNIFICANCE. FURTHER, LESS IS KNOWN ABOUT THE IMPORTANCE OF VP24 INTERACTION WITH OTHER HOST PROTEINS. IN A PRELIMINARY AFFINITY PURIFICATION-MASS SPECTROMETRY (AP-MS) PROTEOMIC SCREEN, WE DEMONSTRATED THAT SEVERAL HOST PROTEINS IDENTIFIED AS WILDTYPE VP24 INTERACTORS WERE NOT IDENTIFIED AS INTERACTORS FOR VP24 IMPA-BINDING MUTANTS. HOST PROTEINS THAT WERE IDENTIFIED AS INTERACTORS FOR WILDTYPE BUT NOT MUTANT VP24 MAY USE IMPA TO BRIDGE INTERACTION WITH VP24. IN CONTRAST, HOST PROTEINS THAT INTERACT WITH BOTH WILDTYPE AND IMPA BINDING MUTANT VP24S ARE POTENTIAL DIRECT VP24 INTERACTORS. THEREFORE, I HYPOTHESIZE THAT VP24 CAN INTERACT WITH HOST PROTEINS THROUGH IMPA-INDEPENDENT AND DEPENDENT BINDING MODES, WITH IMPA-BINDING ACTING AS A MECHANISM TO EXPAND THE RANGE OF HOST PROTEINS TARGETED BY VP24. I ALSO HYPOTHESIZE THAT BOTH MODES OF INTERACTION ARE FUNCTIONALLY SIGNIFICANT FOR EBOV REPLICATION. THE GOAL OF THIS PROJECT IS TO DEFINE THE CHARACTERISTICS AND MECHANISTIC SIGNIFICANCE OF THESE TWO VP24 BINDING MODES BY EXAMINING REPRESENTATIVE HOST PROTEINS IDENTIFIED IN OUR AP- MS STUDIES, WITH THE HOST PROTEIN ANP32A REPRESENTING IMPA-DEPENDENT VP24 INTERACTORS AND EMD AND ATP1A1 REPRESENTING IMPA-INDEPENDENT VP24 INTERACTORS. IN AIM 1, WE WILL USE STRUCTURAL AND MUTATIONAL APPROACHES TO CHARACTERIZE CRUCIAL BINDING DETERMINANTS THAT MEDIATE IMPA-DEPENDENT AND INDEPENDENT INTERACTIONS. IN AIM 2, WE WILL EXAMINE THE FUNCTIONAL SIGNIFICANCE OF THESE BINDING MODES. USING OUR TRANSCRIPTION AND REPLICATION COMPETENT VIRUS-LIKE PARTICLE (TRVLP) EBOV LIFE CYCLE MODELING SYSTEM, WE WILL EXAMINE THE IMPACT OF THESE HOST PROTEINS ON DIFFERENT STAGES OF THE EBOV LIFE CYCLE. WE WILL ALSO USE THE PREVIOUSLY DESCRIBED EBOLAVP30-EGFP VIRUS TO EXAMINE HOW THESE HOST PROTEINS IMPACT VIRAL REPLICATION. THE RESULTS FROM THESE STUDIES WILL PROVIDE ADDITIONAL CLARITY ABOUT THE IMPORTANCE OF THE VP24-IMPA INTERACTION AND PROVIDE NOVEL INSIGHT INTO CELLULAR PROCESSES TARGETED BY VP24. TOGETHER, THESE FINDINGS WILL ADVANCE OUR UNDERSTANDING OF THE CRUCIAL ROLE FOR VP24 IN EBOV REPLICATION. THE STUDIES PROPOSED HERE WILL ALSO HELP FURTHER MY PERSONAL CAREER GOALS BY PROVIDING NEW TRAINING IN FILOVIRUSES, NUCLEAR TRAFFICKING, STRUCTURAL BIOLOGY AND NEW MEANS TO EXAMINE VIRUS-HOST INTERACTIONS.

Posted 7/12/24, 12:00 AM